A novel dysfunctional growth hormone variant (Ile179Met) exhibits a decreased ability to activate the extracellular signal-regulated kinase pathway.
Lewis MD, Horan M, Millar DS, Newsway V, Easter TE, Fryklund L, Gregory JW, Norin M, Del Valle CJ, López-Siguero JP, Cañete R, López-Canti LF, Díaz-Torrado N, Espino R, Ulied A, Scanlon MF, Procter AM, Cooper DN.
Lewis MD, et al. Among authors: scanlon mf.
J Clin Endocrinol Metab. 2004 Mar;89(3):1068-75. doi: 10.1210/jc.2003-030652.
J Clin Endocrinol Metab. 2004.
PMID: 15001589